Georgia's Online Cancer Information Center


back

Anal Cancer Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = Anal Cancer
Cancer Type = Anal Cancer
NCI ID Cancer Type Trial Name
There are currently 3 active Anal Cancer clinical trials in Georgia.
NCI ID Cancer Type Trial Name
1.
EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients
Cancer Type
Anal Cancer, Unknown Primary
NCT ID
NCT04444921
Protocol IDs
EA2176
EA2176
NCI-2020-04334
Treatment Sites (1)
Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital
Thomasville
2.
Evaluation of Sexual Toxicities in Women After Pelvic Radiotherapy
Cancer Type
Anal Cancer, Cervical Cancer, Colon/Rectal Cancer, Gynecologic Cancers, Solid Tumor, Uterine Cancer
NCT ID
NCT05394428
Protocol IDs
20-2369
NCI-2022-05850
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
Scott Edelman
404-778-5180
3.
VGX-3100 and Electroporation in Treating Patients with HIV-Positive High-Grade Anal Lesions
Cancer Type
Anal Cancer, Unknown Primary
NCT ID
NCT03603808
Protocol IDs
AMC-103
AMC-103
NCI-2017-01740
About Us Research Resources & Education Screening & Genetics Clinical Trials & Providers Cancer Navigators Survivorship Media, News & Events Contact Us Donate Take Our Survey Link to Us

Research

Screening & Genetics

Clinical Trials & Providers

Survivorship

About Georgia CORE

Education & Resources

Media, News & Events

Patient Navigation

Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.